Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 23, Issue 4, Pages R185-R205
Publisher
Bioscientifica
Online
2016-05-24
DOI
10.1530/erc-15-0555
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.
- (2017) Marcia S. Brose et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
- (2015) Maria E. Cabanillas et al. CANCER
- Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
- (2015) Y. Koguchi et al. CANCER RESEARCH
- A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
- (2015) M. Schlumberger et al. CLINICAL CANCER RESEARCH
- Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
- (2015) Francis Worden et al. ENDOCRINE-RELATED CANCER
- Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group
- (2015) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E-Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience
- (2015) Ramona Dadu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
- (2015) Elizabeth G. Grubbs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
- (2015) Mingzhao Xing et al. JOURNAL OF CLINICAL ONCOLOGY
- Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma
- (2015) Yann Godbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer
- (2015) Jun Ho Ji et al. PLoS Genetics
- Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome
- (2015) Fabián Pitoia et al. Archives of Endocrinology Metabolism
- Upregulation of HGF and c-MET is Associated with Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
- (2014) Bon Seok Koo et al. ANNALS OF SURGICAL ONCOLOGY
- Response to sorafenib treatment in advanced metastatic thyroid cancer
- (2014) Fabian Pitoia Arquivos Brasileiros de Endocrinologia e Metabologia
- Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments
- (2014) Laura D. Locati et al. CANCER
- Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
- (2014) T. Nakaoku et al. CLINICAL CANCER RESEARCH
- Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens
- (2014) Thomas J. Giordano et al. HUMAN PATHOLOGY
- Development and Characterization of a Differentiated Thyroid Cancer Cell Line Resistant to VEGFR-Targeted Kinase Inhibitors
- (2014) Crescent R. Isham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H
- (2014) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
- (2014) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Complete Resolution of Hypercortisolism with Sorafenib in a Patient with Advanced Medullary Thyroid Carcinoma and Ectopic ACTH (Adrenocorticotropic Hormone) Syndrome
- (2014) Romualdo Barroso-Sousa et al. THYROID
- Definition and management of radioactive iodine-refractory differentiated thyroid cancer
- (2014) Martin Schlumberger et al. Lancet Diabetes & Endocrinology
- Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
- (2013) E. Fox et al. CLINICAL CANCER RESEARCH
- Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy
- (2013) Devron R. Shah et al. DRUG SAFETY
- Radioactive iodine in the treatment of medullary thyroid carcinoma: a controlled multicenter study
- (2013) J A A Meijer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- (2013) Mingzhao Xing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
- (2013) R. C. Smallridge et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversal of Cushing's Syndrome by Vandetanib in Medullary Thyroid Carcinoma
- (2013) Camille Baudry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer
- (2013) C. R. Isham et al. Science Translational Medicine
- Thyroid Cancer Incidence Patterns in Sao Paulo, Brazil, and the U.S. SEER Program, 1997–2008
- (2013) Lene H.S. Veiga et al. THYROID
- Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma
- (2013) Julie A. Sosa et al. THYROID
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2012) Bassam Estfan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A Missing Link in Genotype-Directed Cancer Therapy
- (2012) René Bernards CELL
- Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
- (2012) Vincenzo Marotta et al. CLINICAL ENDOCRINOLOGY
- Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma
- (2012) Maria E Cabanillas et al. ENDOCRINE-RELATED CANCER
- Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
- (2012) Cristina Romei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer
- (2012) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
- (2012) Sophie Leboulleux et al. LANCET ONCOLOGY
- RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation
- (2012) P Ballerini et al. LEUKEMIA
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- Advances in the follow-up of differentiated or medullary thyroid cancer
- (2012) Rossella Elisei et al. Nature Reviews Endocrinology
- Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
- (2012) Shu-Fu Lin et al. PLoS One
- Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
- (2012) K. Ohashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imatinib Enhances Docetaxel-Induced Apoptosis Through Inhibition of Nuclear Factor-κB Activation in Anaplastic Thyroid Carcinoma Cells
- (2012) EunSook Kim et al. THYROID
- Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
- (2012) Raffaele Ciampi et al. THYROID
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
- (2012) Panayiotis Savvides et al. THYROID
- Higher rate of BRAF mutation in papillary thyroid cancer over time
- (2011) Aarti Mathur et al. CANCER
- Cancer cells harboring MET gene amplification activate alternative signaling pathways to escape MET inhibition but remain sensitive to Hsp90 inhibitors
- (2011) Suiquan Wang et al. CELL CYCLE
- Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer
- (2011) N. Jin et al. CLINICAL CANCER RESEARCH
- Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
- (2011) Paula Soares et al. CURRENT GENOMICS
- Molecular Analysis of Thyroid Tumors
- (2011) Feriyl Bhaijee et al. ENDOCRINE PATHOLOGY
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
- (2011) Debyani Chakravarty et al. JOURNAL OF CLINICAL INVESTIGATION
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Multikinase inhibitors: a new option for the treatment of thyroid cancer
- (2011) Matti L. Gild et al. Nature Reviews Endocrinology
- Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
- (2011) Akira Miyauchi et al. THYROID
- THE EFFECT OF RADIOACTIVE IODINE TREATMENT ON THYROID C CELLS
- (2010) MIYASE BAYRAKTAR et al. CLINICAL ENDOCRINOLOGY
- Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib
- (2010) Brady Stein et al. CLINICAL THERAPEUTICS
- Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
- (2010) D. Deandreis et al. ENDOCRINE-RELATED CANCER
- VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma
- (2010) Z Karaca et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus
- (2010) Dingxie Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- BRAF V600E mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer
- (2010) Monica Zerilli et al. MODERN PATHOLOGY
- Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer
- (2010) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Increased Expression of Vascular Endothelial Growth Factor and Its Receptors, VEGFR-1 and VEGFR-2, in Medullary Thyroid Carcinoma
- (2010) Clarissa Capp et al. THYROID
- Expression of hypoxia-inducible factor 1α in thyroid carcinomas
- (2009) N Burrows et al. ENDOCRINE-RELATED CANCER
- Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
- (2009) Ning Jin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
- (2008) Robert C Smallridge et al. ENDOCRINE-RELATED CANCER
- Intragenic Mutations in Thyroid Cancer
- (2008) Manuel Sobrinho-Simões et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
- (2008) Anne Laure Giraudet et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
- (2008) Zhi Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer
- (2007) Libero Santarpia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinicopathological Analysis of Papillary Thyroid Cancer withPIK3CAAlterations in a Middle Eastern Population
- (2007) Jehad Abubaker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now